This month The Block Firm obtained final approval of a $46.5 million class action settlement, which will benefit over a million class members nationwide. The settlement, in the case of Faulkner v. Acella Pharmaceuticals (N.D. Ga.), resolves allegations that a drugmaker sold a defective thyroid medication on the basis of false advertising about the drug’s active ingredient. Eligible class members are entitled to receive reimbursement for up to three months of their prescription costs. More information about the settlement is available here: https://nptsettlement.com.
The Block Firm is proud to have prosecuted this case. Americans are entitled to trust the safety and efficacy of their prescription drugs. Private litigation of this type is an essential tool in ensuring the integrity of the nation’s drug supply system.
